NEFL and Alzheimer disease: The diagnostic performance of plasma ATN biomarkers alone to differentiate AD from NC was acceptable, the discriminant validity was NfL, Aβ42/Aβ40 ratio, and p-tau181 in descending order, and their AUC values were 0.833, 0.776, and 0.773, respectively (Figure 6A).